Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation

References

• JenningsDLMartinezBMontalvoSLanfearDEImpact of pre-implant amiodarone exposure on outcomes in cardiac transplant recipientsHeart Fail Rev2015205 573 57825925244
   PubMed Web of Science ®Google Scholar
• GiardinaEGSchneiderMBarrMLMyocardial amiodarone and desethylamiodarone concentrations in patients undergoing cardiac transplantationJ Am Coll Cardiol1990164 943 9472212375
   PubMed Web of Science ®Google Scholar
• KonertzWWeyandMDeiwickMScheldHHIs pretransplant anti-arrhythmic drug therapy a risk factor?Transplant Proc1992246 2677 26781465898
   PubMed Web of Science ®Google Scholar
• BlombergPJFeingoldADDenofrioDComparison of survival and other complications after heart transplantation in patients taking amiodarone before surgery versus those not taking amiodaroneAm J Cardiol2004933 379 38114759399
   PubMed Web of Science ®Google Scholar
• YerebakanHNakaYSorabellaRAmiodarone treatment prior to heart transplantation is associated with acute graft dysfunction and early mortality: a propensity-matched comparisonJ Heart Lung Transplant2014334 Suppl S105
   Web of Science ®Google Scholar
• Sanchez-LazaroIJAlmenarLMartinez-DolzLDoes amiodarone influence early mortality in heart transplantation?Transplant Proc2006388 2537 253817097993
   PubMed Web of Science ®Google Scholar
• MacdonaldPHackworthyRKeoghASivathasanCChangVSprattPThe effect of chronic amiodarone therapy before transplantation on early cardiac allograft functionJ Heart Lung Transplant199110 743 7491958681
   PubMed Web of Science ®Google Scholar
• Chelimsky-FallickCMiddlekauffHRStevensonWGAmiodarone therapy does not compromise subsequent heart transplantationJ Am Coll Cardiol1992207 1556 15611452930
   PubMed Web of Science ®Google Scholar
• RiviniusRHelmschrottMRuhparwarALong-term use of amiodarone before heart transplantation reduces significantly early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantationDrug Des Devel Ther201610 677 686
   PubMed Web of Science ®Google Scholar
• BacalFBocchiEAVieiraMLPermanent and temporary pacemaker implantation after orthotopic heart transplantationArq Bras Cardiol2000741 9 1210904276
   PubMedGoogle Scholar
• GoldsteinDRCoffeyCSBenzaRLNandaNCBourgeRCRelative perioperative bradycardia does not lead to adverse outcomes after cardiac transplantationAm J Transplant200334 484 49112694073
   PubMed Web of Science ®Google Scholar
• ConnollySJEvidence-based analysis of amiodarone efficacy and safetyCirculation199910019 2025 203410556230
   PubMed Web of Science ®Google Scholar
• SomaniPBasic and clinical pharmacology of amiodarone: relationship of antiarrhythmic effects, dose and drug concentrations to intracellular inclusion bodiesJ Clin Pharmacol1989295 405 4122544634
   PubMed Web of Science ®Google Scholar
• LatiniRTognoniGKatesREClinical pharmacokinetics of amiodaroneClin Pharmacokinet198492 136 1566370540
   PubMed Web of Science ®Google Scholar
• ZipesDPPrystowskyENHegerJJAmiodarone: electrophysiologic actions, pharmacokinetics and clinical effectsJ Am Coll Cardiol198434 1059 10716368644
   PubMed Web of Science ®Google Scholar
• ChinCFeindelCChengDDuration of preoperative amiodarone treatment may be associated with postoperative hospital mortality in patients undergoing heart transplantationJ Cardiothorac Vasc Anesth1999135 562 56610527225
   PubMed Web of Science ®Google Scholar
• RiviniusRHelmschrottMRuhparwarAThe influence of surgical technique on early posttransplant atrial fibrillation – comparison of biatrial, bicaval, and total orthotopic heart transplantationTher Clin Risk Manag201713 287 29728331331
   PubMed Web of Science ®Google Scholar
• RiviniusRHelmschrottMRuhparwarAAnalysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapyDrug Des Devel Ther20149 93 102
   PubMed Web of Science ®Google Scholar
• HelmschrottMBeckendorfJAkyolCSuperior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimenDrug Des Devel Ther20148 1307 1314
   PubMed Web of Science ®Google Scholar
• HelmschrottMRiviniusRRuhparwarAAdvantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantationDrug Des Devel Ther20159 1217 1224
   PubMed Web of Science ®Google Scholar
• DarbyAEDimarcoJPManagement of atrial fibrillation in patients with structural heart diseaseCirculation20121257 945 95722354975
   PubMed Web of Science ®Google Scholar
• DubreySWAn update on treatments for amyloid heart diseaseBr J Cardiol2013203 107
   Google Scholar
• AlkindiSAlmasoudAYounesAIncreased risk of heart block in patients with cardiac amyloidosis on amiodaroneJ Cardiac Fail2015218 Suppl S125
   Web of Science ®Google Scholar
• FalkRHDiagnosis and management of the cardiac amyloidosesCirculation200511213 2047 206016186440
   PubMed Web of Science ®Google Scholar
• KristenAVDenglerTJHegenbartUProphylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac deathHeart Rhythm200852 235 24018242546
   PubMed Web of Science ®Google Scholar
• RadovancevicBKonuralpCVrtovecBFactors predicting 10-year survival after heart transplantationJ Heart Lung Transplant2005242 156 15915701430
   PubMed Web of Science ®Google Scholar
• YamaniMHYousufuddinMStarlingRCDoes acute cellular rejection correlate with cardiac allograft vasculopathy?J Heart Lung Transplant2004233 272 27615019635
   PubMed Web of Science ®Google Scholar
• GrimmMRinaldiMYonanNASuperior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients – a large European trialAm J Transplant200666 1387 139716686762
   PubMed Web of Science ®Google Scholar
• HamerAWArklesLBJohnsJABeneficial effects of low dose amiodarone in patients with congestive cardiac failure: a placebo-controlled trialJ Am Coll Cardiol1989147 1768 17742685081
   PubMed Web of Science ®Google Scholar
• JanuaryCTWannLSAlpertJS2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm SocietyJ Am Coll Cardiol20146421 1 7624998121
   PubMed Web of Science ®Google Scholar
• PedersenCTKayGNKalmanJEHRA/HRS/APHRS expert consensus on ventricular arrhythmiasHeart Rhythm20141110 166 196
   Web of Science ®Google Scholar
• SiddowayLAAmiodarone: guidelines for use and monitoringAm Fam Physician20036811 2189 219614677664
   PubMed Web of Science ®Google Scholar
• MonteroJAAnguitaMConchaMPacing requirements after orthotopic heart transplantation: incidence and related factorsJ Heart Lung Transplant1992114 Pt 1 799 8021498147
   PubMed Web of Science ®Google Scholar
• BertoletBDEagleDAContiJBMillsRMBelardinelliLBradycardia after heart transplantation: reversal with theophyllineJ Am Coll Cardiol1996282 396 3998800116
   PubMed Web of Science ®Google Scholar
• ZierothSRossHRaoVPermanent pacing after cardiac transplantation in the era of extended donorsJ Heart Lung Transplant2006259 1142 114716962478
   PubMed Web of Science ®Google Scholar
• WooGWSchofieldRSPaulyDFIncidence, predictors, and outcomes of cardiac pacing after cardiac transplantation: an 11-year retrospective analysisTransplantation2008858 1216 121818431245
   PubMed Web of Science ®Google Scholar
• HohnloserSHPajitnevDPogueJIncidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W SubstudyJ Am Coll Cardiol20075022 2156 216118036454
   PubMed Web of Science ®Google Scholar
• HohnloserSHMeinertzTDammbacherTElectrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled studyAm Heart J19911211 Pt 1 89 951985383
   PubMed Web of Science ®Google Scholar
• DaoudEGStrickbergerSAManKCPreoperative amiodarone as prophylaxis against atrial fibrillation after heart surgeryN Engl J Med199733725 1785 17919400034
   PubMed Web of Science ®Google Scholar
• GuarnieriTNolanSGottliebSODudekALowryDRIntravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trialJ Am Coll Cardiol1999342 343 34710440143
   PubMed Web of Science ®Google Scholar
• GiriSWhiteCMDunnABOral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trialLancet20013579259 830 83611265951
   PubMed Web of Science ®Google Scholar
• WhiteCMCaronMFKalusJSIntravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: the Atrial Fibrillation Suppression Trial II (AFIST II)Circulation2003108Suppl 1 II200 II20612970233
   PubMed Web of Science ®Google Scholar
• MitchellLBExnerDVWyseDGProphylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPABEAR: a randomized controlled trialJAMA200529424 3093 310016380589
   PubMed Web of Science ®Google Scholar
• BudeusMHennersdorfMPeringsSAmiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized studyEur Heart J20062713 1584 159116760210
   PubMed Web of Science ®Google Scholar
• ButlerJHarrissDRSinclairMWestabySAmiodarone prophylaxis for tachycardias after coronary artery surgery: a randomised, double blind, placebo controlled trialBr Heart J1993701 56 608038000
   PubMedGoogle Scholar
• RedleJDKhuranaSMarzanRProphylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgeryAm Heart J19991381 Pt 1 144 15010385778
   PubMed Web of Science ®Google Scholar
• MarasDBoskovićSDPopovićZSingle-day loading dose of oral amiodarone for the prevention of new-onset atrial fibrillation after coronary artery bypass surgeryAm Heart J20011415 E811320383
   PubMedGoogle Scholar
• BeaulieuYDenaultAYCouturePPerioperative intravenous amiodarone does not reduce the burden of atrial fibrillation in patients undergoing cardiac valvular surgeryAnesthesiology20101121 128 13719996947
   PubMed Web of Science ®Google Scholar
• YamreudeewongWDeBisschopMMartinLGLowerDLPotentially significant drug interactions of class III antiarrhythmic drugsDrug Saf2003266 421 43812688833
   PubMed Web of Science ®Google Scholar
• FreitagDBebeeRSunderlandBDigoxin-quinidine and digoxin- amiodarone interactions: frequency of occurrence and monitoring in Australian repatriation hospitalsJ Clin Pharm Ther1995203 179 1837593381
   PubMed Web of Science ®Google Scholar